Dassault Systèmes SE (EPA:DSY)
France flag France · Delayed Price · Currency is EUR
19.60
+0.33 (1.71%)
Apr 24, 2026, 5:38 PM CET

Dassault Systèmes SE Earnings Call Transcripts

Fiscal Year 2026

  • Q1 2026 delivered 3% revenue growth and strong cash flow, with recurring ARR up 6% and robust performance in Mainstream Innovation and cloud. Full-year guidance is confirmed, with acceleration expected in H2 and continued investment in AI and M&A.

  • Q1 2026 saw 3% revenue growth, strong cash flow, and robust ARR expansion, with momentum in cloud, 3DEXPERIENCE, and mainstream innovation. Full-year guidance is confirmed, with acceleration expected in H2, while strategic deals and AI-driven offerings support long-term growth.

  • Investor update

    A leadership transition sees Pascal Daloz appointed Chairman and CEO, ensuring continuity and acceleration of the Industrial AI strategy centered on 3D UNIV+RSES. Bernard Charlès remains as a technology advisor, while management and product innovation efforts are being reinforced to drive growth.

Fiscal Year 2025

  • 2025 saw modest growth and operational challenges, but recurring revenue and cloud adoption increased, with new AI-powered solutions and 3D Universes introduced. 2026 guidance targets improved margins and a continued shift to subscription and ARR metrics.

  • 2025 saw modest growth amid macro and segment headwinds, but strategic progress in cloud, AI, and 3DEXPERIENCE set the stage for 2026. Guidance for 2026 is cautious, with a focus on subscription transition, ARR, and margin improvement, while new AI-driven solutions and partnerships drive future growth.

  • Q3 saw 5% revenue growth, 16% subscription growth, and 100 bps margin expansion, with strong industrial innovation offsetting Medidata and Centric softness. Full-year revenue guidance was lowered, but EPS targets were maintained, as the shift to recurring and subscription revenue accelerates.

  • Q3 saw 5% revenue growth, 10% EPS growth, and a 30.1% operating margin, driven by strong industrial innovation and subscription momentum. Life sciences faced headwinds from lower clinical trial starts, but major contract wins and AI-driven offerings support long-term growth.

  • Q2 and H1 2025 saw accelerating revenue growth, strong subscription and 3DEXPERIENCE momentum, and robust performance in manufacturing, aerospace, and high-tech. Guidance for 2025 is maintained, with continued investment in AI, automation, and strategic acquisitions supporting long-term growth.

  • Q2 and H1 2025 saw accelerating revenue growth, strong subscription and 3DEXPERIENCE momentum, and resilient performance across key sectors. Full-year guidance is maintained, with continued investment in AI, cloud, and automation, despite FX and market volatility.

  • CMD 2025

    A new strategic era centers on AI for industry and 3D UNIV+RSES, driving a shift to IP-based business models and virtual twin experiences. Financial targets include doubling EPS by 2029, with 3D UNIV+RSES and generative AI contributing €1B in revenue. Rapid adoption is seen across automotive, manufacturing, life sciences, and consumer sectors.

  • Q1 2025 delivered strong software and subscription growth, with 3DEXPERIENCE and cloud adoption accelerating. Guidance for 2025 is maintained despite tariff-driven volatility, and strategic investments in AI, cloud, and life sciences are expected to drive future growth.

  • Q1 2025 saw strong subscription and 3D Experience growth, with EPS at the high end of guidance. Full-year outlook remains unchanged despite macro volatility, with investments in Gen7 and cloud driving future growth. Strategic deals and acquisitions support resilience across key sectors.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020

Fiscal Year 2019

Fiscal Year 2018

Powered by